# EDGAR Filing Document

**Accession Number:** 0001866547
**File Stem:** 0001641172-25-021706
**Filing Date:** 2025-7
**Character Count:** 107096
**Document Hash:** aeeb99799a49b335b78de9a136a7f644
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-021706.hdr.sgml**: 20250731

**ACCESSION NUMBER**: 0001641172-25-021706

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 47

**CONFORMED PERIOD OF REPORT**: 20240930

**FILED AS OF DATE**: 20250731

**DATE AS OF CHANGE**: 20250731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aetherium Acquisition Corp
- **CENTRAL INDEX KEY:** 0001866547
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41189
- **FILM NUMBER:** 251171012

**BUSINESS ADDRESS:**
- **STREET 1:** 79B PEMBERWICK RD.
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06831
- **BUSINESS PHONE:** (650) 450-6836

**MAIL ADDRESS:**
- **STREET 1:** 79B PEMBERWICK RD.
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06831

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2024**

**☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to**

**Commission File No. 001-41189**

**AETHERIUM ACQUISITION CORP.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **86-3449713** |
| (State or other jurisdiction<br> of incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **79B Pemberwick Rd.**<br> **Greenwich, CT** | **06831** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

**(650) 450-6836**

(Registrant's telephone number, including area code)

**N/A**

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Units, each consisting of one share of Class A Common Stock and one Redeemable Warrant | GMFIU | The Nasdaq Stock Market LLC |
| Class A Common Stock, par value $0.0001 per share | GMFI | The Nasdaq Stock Market LLC |
| Warrants | GMFIW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of July 17, 2025, there were 5,105,784 shares of Class A common stock, par value $0.0001 per share, and 1 shares of Class B common stock, par value $0.0001 per share, issued and outstanding.

**AETHERIUM ACQUISITION CORP.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| [**PART I – FINANCIAL INFORMATION:**](#a_001) | [**PART I – FINANCIAL INFORMATION:**](#a_001) | 1 |
| Item 1. | [Financial Statements:](#a_002) | 1 |
|  | [Balance Sheets as of September 30, 2024 and December 31, 2023 (Unaudited)](#a_002) | 1 |
|  | [Statements of Operations for the Three and Nine Months Ended September 30, 2024 and September 30, 2023 (Unaudited)](#a_004) | 2 |
|  | [Statements of Changes in Stockholders' Deficit for the Three and Nine Months Ended September 30, 2024 and September 30, 2023 (Unaudited)](#a_005) | 3 |
|  | [Statements of Cash Flows for the Nine Months Ended September 30, 2024 and September 30, 2023 (Unaudited)](#a_006) | 4 |
|  | [Notes to Financial Statements (Unaudited)](#a_007) | 5 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#sq_001) | 18 |
| Item 3. | [Quantitative and Qualitative Disclosures About Market Risk](#sq_002) | 22 |
| Item 4. | [Controls and Procedures](#sq_003) | 22 |
| **[PART II - OTHER INFORMATION:](#sq_004)** | **[PART II - OTHER INFORMATION:](#sq_004)** | 22 |
| Item 1. | [Legal Proceedings](#sq_005) | 22 |
| Item 1A. | [Risk Factors](#sq_006) | 22 |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#sq_007) | 22 |
| Item 3. | [Defaults Upon Senior Securities](#sq_008) | 23 |
| Item 4. | [Mine Safety Disclosures](#sq_009) | 23 |
| Item 5. | [Other Information](#sq_010) | 23 |
| Item 6. | [Exhibits](#sq_011) | 23 |

---

**PART I - FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**AETHERIUM ACQUISITION CORP.**

**BALANCE SHEETs**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **September 30, 2024** | **December 31, 2023** |
| **ASSETS** |  |  |
| &nbsp;&nbsp;&nbsp;Cash | $207 | $4 |
| &nbsp;&nbsp;&nbsp;Cash and marketable securities held in trust account | 19558236 | 32931063 |
| &nbsp;&nbsp;&nbsp;**Total Current Assets** | 19558443 | 32931067 |
| **Total Assets** | $**19558443** | $**32931067** |
| **LIABILITIES AND STOCKHOLDERS' DEFICIT** |  |  |
| &nbsp;&nbsp;&nbsp;Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accrued expenses | $1541160 | $917117 |
| &nbsp;&nbsp;&nbsp;Franchise tax payable | 268850 | 400100 |
| &nbsp;&nbsp;&nbsp;Income tax payable | 648347 | 868297 |
| &nbsp;&nbsp;&nbsp;Excise tax payable | 1029655 | 883507 |
| &nbsp;&nbsp;&nbsp;Working capital loan – related party | 821631 | 537431 |
| &nbsp;&nbsp;&nbsp;Extension loans – related party | 1800000 | 885000 |
| &nbsp;&nbsp;&nbsp;Deferred underwriter fee payable | 4025000 | 4025000 |
| &nbsp;&nbsp;&nbsp;**Total Current Liabilities** | 10134643 | 8516452 |
| **Total Liabilities** | **10134643** | **8516452** |
| **Commitments and Contingencies (Note 6)** |  |  |
| &nbsp;&nbsp;&nbsp;Class A common stock subject to possible redemption; 1,702,285 and 2,991,003 shares (at redemption value of $10.95 and $10.59 per share as of September 30, 2024 and December 31, 2023, respectively) | 18641040 | 31662667 |
| **Stockholders' Deficit** |  |  |
| &nbsp;&nbsp;&nbsp;Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;Class A common shares, $0.0001 par value; 100,000,000 shares authorized; 3,403,499 and 528,500 (excluding 1,702,285 and 2,991,003 Class A shares subject to redemption as of September 30, 2024 and December 31, 2023, respectively) issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | 340 | 53 |
| &nbsp;&nbsp;&nbsp;Class B common shares, par value $0.0001; 10,000,000 shares authorized; 1 and 2,875,000 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively | 1 | 288 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital |  |  |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (9217581) | (7248393) |
| **Total Stockholders' Deficit** | **(9217240)** | **(7248052)** |
| **Total Liabilities and Stockholders' Deficit** | $**19558443** | $**32931067** |

---

The accompanying notes are an integral part of these unaudited financial statements

**AETHERIUM ACQUISITION CORP.**

**STATEMENTS OF OPERATIONS**

**(UNAUDITED)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the<br> Three<br> Months<br> Ended<br> September 30,<br> 2024** | **For the<br> Nine<br> Months<br> Ended<br> September 30,<br> 2024** | **For the<br> Three<br> Months<br> Ended<br> September 30,<br> 2023** | **For the<br> Nine<br> Months<br> Ended<br> September 30,<br> 2023** |
| Formation and operating costs | $(377545) | $(907192) | $(121825) | $(398923) |
| Franchise tax | (50000) | (150000) | (50000) | (150000) |
| &nbsp;&nbsp;&nbsp;**Loss from operations** | **(427545)** | **(1057192)** | **(171825)** | **(548923)** |
| Other income: |  |  |  |  |
| Investment income earned on investments held in Trust Account | 208418 | 1007382 | 405954 | 2328876 |
| Total other income | 208418 | 1007382 | 405954 | 2328876 |
| Income (loss) before provision for income taxes | (219127) | (49810) | 234129 | 1779953 |
| Provision for income taxes | (33268) | (180050) | (74750) | (457564) |
| **Net income (loss)** | $**(252395)** | $**(229860)** | $**159379** | $**1322389** |
| Weighted average shares outstanding of Class A common stock, basic and diluted | 5105784 | 4294916 | 3519503 | 6075319 |
| **Basic and diluted net income (loss) per common stock** | $**(0.05)** | $**(0.04)** | $**0.02** | $**0.15** |
| Weighted average shares outstanding of Class B common stock, basic and diluted | 1 | 1427008 | 2875000 | 2875000 |
| **Basic and diluted net income (loss) per common stock** | $**(0.00)** | $**(0.04)** | $**0.02** | $**0.15** |

---

The accompanying notes are an integral part of these unaudited financial statements.

**AETHERIUM ACQUISITION CORP.**

**STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT**

**FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2024 (UNAUDITED)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A** <br> **Common Stock** | **Class A** <br> **Common Stock** | **Class B** <br> **Common Stock** | **Class B** <br> **Common Stock** | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br> **Paid in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total**<br> **Stockholders'**<br>**Deficit** |
| **Balance - January 1, 2024** | **528500** | $**53** | **2875000** | $**288** | $**&nbsp;&nbsp;&nbsp;&nbsp; -** | $**(7248393)** | $**(7248052)** |
| Re-measurement of Class A common stock subject to redemption |  |  |  |  |  | (375371) | (375371) |
| Extension funds attributable to common stock subject to redemption |  |  |  |  |  | (766148) | (766148) |
| Net loss | - | - | - | - | - | (83777) | (83777) |
| **Balance – March 31, 2024** | **528500** | $**53** | **2875000** | $**288** | $**-** | $**(8473689)** | $**(8473348)** |
| Re-measurement of Class A common stock subject to redemption | **-** | **-** | **-** | **-** | **-** | (176512) | (176512) |
| Extension funds attributable to common stock subject to redemption | **-** | **-** | **-** | **-** | **-** | (150000) | (150000) |
| Excise tax liability | **-** | **-** | **-** | **-** | **-** | (146148) | (146148) |
| Class B conversion | 2874999 | 287 | (2874999) | (287) | **-** | **-** | **-** |
| Net income | - | - | - | - | - | 106312 | 106312 |
| **Balance – June 30, 2024** | **3403499** | $**340** | **1** | $**1** | $**-** | $**(8840037)** | $**(8839696)** |
| Re-measurement of Class A common stock subject to redemption | **-** | **-** | **-** | **-** | **-** | (125149) | (125149) |
| Net loss | **-** | **-** | **-** | **-** | **-** | (252395) | (252395) |
| **Balance – September 30, 2024** | **3403499** | $**340** | **1** | $**1** | $**-** | $**(9217581)** | **(9217240)** |

---

**STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT**

**FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023**

**(UNAUDITED)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A** <br> **Common Stock** | **Class A** <br> **Common Stock** | **Class B** <br> **Common Stock** | **Class B** <br> **Common Stock** | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br> **Paid in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total**<br> **Stockholders'**<br>**Deficit** |
| **Balance - January 1, 2023** | **528500** | $**53** | **2875000** | $**288** | $**&nbsp;&nbsp;&nbsp;&nbsp; -** | $**(4992245)** | $**(4991904)** |
| Re-measurement of Class A common stock subject to redemption |  |  |  |  |  | (490213) | (490213) |
| Net income | - | - | - | - | - | 658134 | 658134 |
| **Balance – March 31, 2023** | **528500** | $**53** | **2875000** | $**288** | $**-** | $**(4824324)** | $**(4823983)** |
| Re-measurement of Class A common stock subject to redemption |  |  |  |  |  | (542132) | (542132) |
| Extension funds attributable to common stock subject to redemption |  |  |  |  |  | (285000) | (285000) |
| Net income | - | - | - | - | - | 504876 | 504876 |
| **Balance – June 30, 2023** | **528500** | $**53** | **2875000** | $**288** | $**-** | $**(5146580)** | $**(5146239)** |
| Re-measurement of Class A common stock subject to redemption |  |  |  |  |  | (281805) | (281805) |
| Extension funds attributable to common stock subject to redemption |  |  |  |  |  | (300000) | (300000) |
| Net income | - | - | - | - | - | 159379 | 159379 |
| **Balance – September 30, 2023** | **528500** | $**53** | **2875000** | $**288** | $**-** | $**(5568406)** | $**(5568065)** |

---

The accompanying notes are an integral part of these unaudited financial statements

**AETHERIUM ACQUISITION CORP.**

**STATEMENTS OF CASH FLOWS**

**(UNAUDITED)**

---

| | | |
|:---|:---|:---|
|  | **For the Nine**<br> **Months Ended**<br> **September 30, 2024** | **For the Nine**<br> **Months Ended**<br> **September 30, 2023** |
| **Cash flow from operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Net income (loss) | $(229860) | $1322389 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment income earned on investments held in Trust Account | (1007382) | (2328876) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expenses paid by related party | 284200 | 31679 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Changes in operating assets and liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Franchise tax payable | (131250) | 150000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax payable | (219950) | 187544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 624043 | 351934 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in operating activities** | **(680199)** | **(285330)** |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash withdrawn from trust account in connection with redemptions | 14614808 | 88350715 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash withdrawn from trust account for tax obligations | 681550 | 270000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment of cash in trust account | (916148) | (585000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by investing activities** | **14380210** | **88035715** |
| **Cash flow from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Redemption of Class A common stock | (14614808) | (88350715) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from extension loan | 915000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from working capital loan | - | 600000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in financing activities** | **(13699808)** | **(87750715)** |
| **Net change in cash** | **203** | **(330)** |
| Cash at the beginning of the period | 4 | 334 |
| **Cash at the end of the period** | $**207** | $**4** |
| **Supplemental disclosure of non-cash financing activities:** |  |  |
| Amount deposited into Trust Account for extension | $- | $585000 |
| Extension funds attributable to common stock subject to redemption | 916148 | - |
| Excise tax liability | $146148 | $- |
| Re-measurement of Class A common stock subject to redemption | $677032 | $1313550 |

---

The accompanying notes are an integral part of these unaudited financial statements

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 1 — Description of Organization and Business Operations**

Aetherium Acquisition Corp. (the "Company") is a blank check company incorporated in the State of Delaware on April 15, 2021. The Company was formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities ("Business Combination"). While the Company may pursue an initial business combination target in any business, industry or sector or geographical location, the Company intends to focus on businesses in the education, training and education technology ("EdTech") industries, specifically in Asia (excluding China). The Company's amended and restated certificate of incorporate will provide that the Company shall not undertake an initial business combination with any entity with its principal business operations in China (including Hong Kong and Macau).

As of September 30, 2024, the Company had not commenced any operations. All activity for the period from April 15, 2021 (inception) through September 30, 2024 relates to the Company's formation and the Initial Public Offering (as defined below) and searching for a target company. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

The Company's sponsor is Aetherium Capital Holdings LLC, a Delaware limited liability company (the "Sponsor"). The registration statement for the Company's initial public offering was declared effective on December 29, 2021. On January 3, 2022, the Company consummated its Initial Public Offering of 11,500,000 units (the "Units" and, with respect to the shares of Class A common stock included in the Units being offered, the "Public Shares"), at $10.00 per Unit, generating gross proceeds of $115,000,000 (the "Initial Public Offering," or "IPO"), and incurring offering costs of $6,762,886, of which $4,025,000 was for deferred underwriting commissions (see Note 6). The Company granted the underwriter a 45-day option to purchase up to an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. On January 3, 2022, the over-allotment option was exercised in full.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement of an aggregate of 528,500 units (the "Placement Units") to the Sponsor at a price of $10.00 per Placement Unit, generating total gross proceeds of $5,285,000 (the "Private Placement") (see Note 4).

Following the closing of the Initial Public Offering on January 3, 2022, an amount of $116,725,000 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and a portion of the proceeds from the sale of the Placement Units was placed in a trust account (the "Trust Account"), located in the United States and held as cash items or may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company's stockholders, as described below.

The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 1 — Description of Organization and Business Operations (Continued)**

If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company's Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company's prior written consent.

The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company's warrants. These shares of Class A common stock will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification ("ASC") Topic 480 "Distinguishing Liabilities from Equity."

If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the Securities and Exchange Commission ("SEC"), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.

The Sponsor has agreed (a) to vote its shares of Class B common stock, the shares of Class A common stock included in the Placement Units (the "Placement Shares") and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company's Amended and Restated Certificate of Incorporation with respect to the Company's pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Class B common stock) and Placement Units (including underlying securities) into the right to receive cash from the Trust Account in connection with a stockholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek stockholder approval in connection therewith) or a vote to amend the provisions of the Amended and Restated Certificate of Incorporation relating to stockholders' rights of pre-Business Combination activities and (d) that the Class B common stock and Placement Units (including underlying securities) shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination.

The Company had 15 months from the closing of the Initial Public Offering (See Note 3) to consummate a Business Combination (the "Combination Period"). On March 23, 2023, the Company held a special meeting of its stockholders (the "Special Meeting"). At the Special Meeting, the Company's stockholders approved the proposal to amend the Company's amended and restated certificate of incorporation, to extend the date by which the Company must consummate a business combination up to twelve (12) times, each such extension for an additional one (1) month period from April 3, 2023 to April 3, 2024, by depositing into the trust account established for the benefit of the Company's public stockholders the lesser of (A) $0.055 per non-redeeming publicly held share of common stock and (B) $150,000 (the "Extension Payment") for each one-month extension. In connection with such proposal, stockholders elected to redeem 8,508,997 shares of the Company's Class A common stock, par value $0.0001 per share ("Class A Common Stock"), which represents approximately 74% of the shares that were part of the units that were sold in the Company's IPO. Following such redemptions, 2,991,003 were subject to redemption. On each of April 3, May 3, July 11, and July 31, the Company's Sponsor has deposited into the Company's trust account $150,000 to extend the period of time it has to consummate its initial business combination by six months from April 3, 2023 to October 3, 2023. On December 4, 2023, the Company deposited $300,000 into the Trust Account to further extend the period of time it has to consummate a business combination by six months from December 4, 2023 to June 4, 2024.

On January 17, 2024 the Company deposited $315,000 into the Company's trust account to extend the period of time it has to consummate a business combination by three months from June 4, 2024 to September 4, 2024. On February 14, 2024 the Company deposited $300,000 into the Company's trust account to extend the period of time it has to consummate a business combination by three months from September 4, 2024 to December 4, 2024. On March 21, 2024 the Company deposited $150,000 into the Company's trust account to extend the period of time it has to consummate a business combination by three months from December 4, 2024 to March 4, 2025. On May 9, 2024 the Company deposited $150,000 into the Company's trust account to extend the period of time it has to consummate a business combination by three months from March 4, 2025 to June 5, 2025.

On March 28, 2024, the Company held a special meeting of its stockholders (the "2024 Special Meeting"). At the 2024 Special Meeting, the Company's stockholders approved the proposals including to amend the Company's amended and restated certificate of incorporation, to extend the date by which the Company must consummate a business combination to thirty-six (36) months from the effectiveness date of the Company's Form S-1 by the SEC, which was December 29, 2021, until December 29, 2024, by depositing into the trust account established for the benefit of the Company's public stockholders $0.033 per non-redeeming publicly held share of common stock for each one-month extension.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 1 — Description of Organization and Business Operations (Continued)**

The Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor (other than the independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below $10.15 per share (whether or not the underwriters' over-allotment option is exercised in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company's indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the "Securities Act"). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the company's independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

**Liquidity and Management's Plan**

Prior to the completion of the IPO, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. The Company has since completed its IPO at which time capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses was released to the Company for general working capital purposes. The Company has incurred and expects to continue to incur significant costs in pursuit of our financing and acquisition plans. Management plans to address this uncertainty during period leading up to the business combination. However, there is no assurance that the Company's plans to consummate an initial Business Combination will be successful within the Combination Period.

**Going Concern Consideration**

In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the IPO, the requirement that the Company cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern.

**Inflation Reduction Act of 2022**

On August 16, 2022, the Inflation Reduction Act of 2022 (the "IR Act") was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any "PIPE" or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the U.S. Department of the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company's ability to complete a Business Combination.

As a result of redemptions by the public stockholders on May 10, 2024, the Company accrued the 1% excise tax in the amount of $146,148 as a reduction of retained deficit as of September 30, 2024. As of September 30, 2024 and December 31, 2023 the aggregate excise tax accrued on the Company's balance sheets totals $1,029,655 and $883,507, respectively.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 2 — Summary of Significant Accounting Policies**

**Basis of Presentation**

The accompanying unaudited financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in the annual financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim financial statements as of September 30, 2024 and for the three and nine months ended September 30, 2024 and 2023, respectively, are unaudited. In the opinion of management, the interim financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying balance sheet as of December 31, 2023, is derived from the audited financial statements presented in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. Operating results as presented are not necessarily indicative of the results to be expected for a full year.

**Emerging Growth Company**

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

**Use of Estimates**

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 2 — Summary of Significant Accounting Policies (Continued)**

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

**Cash and Cash Equivalents**

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of September 30, 2024, the Company had $207 of cash in its operating bank account. As of December 31, 2023, the Company had $4 of cash in its operating bank account. As of September 30, 2024 and December 31, 2023, the Company had no cash equivalents.

**Cash and Marketable Securities Held in Trust Account**

To mitigate the risk of the Company being deemed to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act, on or about February 1, 2024, the Company instructed Continental Stock Transfer & Trust Company, pursuant to the executed Second Amendment to the Investment Management Trust Agreement between the Company and Continental Stock Transfer & Trust Company, to liquidate the investments in the money market funds held in the Trust Account immediately and thereafter to hold all funds in the Trust Account in cash in an interest-bearing demand deposit account until the earlier of consummation of our initial business combination or liquidation of the Company. Thus, as of September 30, 2024, substantially all of the assets held in the Trust Account were held in cash in an interest-bearing demand deposit account.

As of December 31, 2023, the Company's portfolio of investments is comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligation. The Company's investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in investment income earned on investment held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. As of December 31, 2023, substantially all of the assets held in the Trust Account were held in U.S. Treasury Securities Money Market Funds.

**Offering Costs Associated with the Initial Public Offering**

Offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering executed on January 3, 2022 and that were charged to stockholders' equity upon the completion of the Initial Public Offering.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 2 — Summary of Significant Accounting Policies (Continued)**

**Warrant Liabilities**

The Company accounts for Warrants as either equity-classified or liability-classified instruments based on an assessment of the Warrant's specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity ("ASC 480") and ASC 815, Derivatives and Hedging ("ASC 815"). The assessment considers whether the Warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the Warrants meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to the Company's own shares of Class A Common Stock and whether the Warrant holders could potentially require "net cash settlement" in a circumstance outside of the Company's control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the Warrants are outstanding.

For issued or modified Warrants that meet all of the criteria for equity classification, the Warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified Warrants that do not meet all the criteria for equity classification, the Warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the Warrants are recognized as a non-cash gain or loss on the statements of operations.

As the warrants issued upon the Initial Public Offering and private placements meet the criteria for equity classification under ASC 815, therefore, the warrants are classified as equity as of September 30, 2024 and December 31, 2023.

**Franchise Tax**

Delaware, where the Company is incorporated, imposes a franchise tax that applies to most business entities that are formed or qualified to do business, or which are otherwise doing business, in Delaware. Delaware franchise tax is based on authorized shares or on assumed par and non-par capital, whichever yields a lower result. Under the authorized shares method, each share is taxed at a graduated rate based on the number of authorized shares. For the nine months ended September 30, 2024 and 2023 the Company incurred $150,000 of franchise tax. As of September 30, 2024 and December 31, 2023, there is franchise tax payable of $268,850 and $400,100, respectively.

**Income Taxes**

The Company complies with the accounting and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company's management determined the United States is the Company's only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits as of September 30, 2024 and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The provision for income taxes for the three and nine months ended September 30, 2024 was $33,268 and $180,050, respectively. The provision for income taxes for the three and nine months ended September 30, 2023 was $74,750 and $457,564, respectively.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 2 — Summary of Significant Accounting Policies (Continued)**

**Net Income (Loss) Per Share**

Net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common stock shares outstanding for the period. The calculation of diluted net income (loss) per share does not consider the effect of the warrants issued in connection with the Initial Public Offering and warrants issued as components of the Private Placement Units (the "Placement Warrants") since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.

Net income (loss) per share, basic and diluted, for Class A and Class B non-redeemable common stock is calculated by dividing the net loss, adjusted for income attributable to Class A redeemable common stock shares, by the weighted average number of Class A and Class B non-redeemable common stock shares outstanding for the period. Non-redeemable Class A and Class B common stock shares includes the Founder Shares and non-redeemable common stock shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.

The following table reflects the calculation of basic and diluted net income per common share:

Schedule of Basic and Diluted Net Income (Loss) Per Common Share

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For The<br> Three<br> Months<br> Ended<br> September 30,<br> 2024** | **For The <br> Nine<br> Months<br> Ended<br> September 30,<br> 2024** | **For The<br> Three<br> Months<br> Ended<br> September 30,<br> 2023** | **For the<br> Nine<br> Months<br> Ended<br> September 30,<br> 2023** |
| Class A common stock |  |  |  |  |
| Numerator: net income (loss) allocable to Class A common stock | $(252395) | $(172535) | $87721 | $897615 |
| Denominator: weighted average number of Class A common stock | 5105784 | 4294916 | 3519503 | 6075319 |
| Basic and diluted net income (loss) per redeemable Class A common stock | $(0.05) | $(0.04) | $0.02 | $0.15 |
| Class B common stock |  |  |  |  |
| Numerator: net income (loss) allocable to Class B common stock | $- | $(57325) | $71658 | $424775 |
| Denominator: weighted average number of Class B common stock | 1 | 1427008 | 2875000 | 2875000 |
| Basic and diluted net income (loss) per Class B common stock | $(0.00) | $(0.04) | $0.02 | $0.15 |

---

**Class A Common Stock Subject to Possible Redemption**

All of the Class A common stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company's liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company's amended and restated certificate of incorporation. In accordance with ASC 480, conditionally redeemable Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company's control) are classified as temporary equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity's equity instruments, are excluded from the provisions of ASC 480. Although the Company did not specify a maximum redemption threshold, its charter provides that currently, the Company will not redeem its public shares in an amount that would cause its net tangible assets (stockholders' equity) to be less than $5,000,001. On May 10, 2024 shareholders holding 1,288,718 elected to redeem such shares for a pro rata portion of the funds in the Company's Trust Account. As a result, $14,614,808 was removed from the Trust Account in connection with the redemption in order to pay such holders. As of September 30, 2024 and December 31, 2023, there are 1,702,285 and 2,991,003 shares of Class A common shares subject to possible redemption in the amount of $18,641,040 and $31,662,667, respectively, at redemption value per Public Share are presented as temporary equity, outside of shareholders' deficit on the Company's balance sheet.

**Concentration of Credit Risk**

Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. As of September 30, 2024, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 2 — Summary of Significant Accounting Policies (Continued)**

**Fair Value of Financial Instruments**

The Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

**Recent Accounting Standards**

Management of the Company does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 3 — Initial Public Offering**

On January 3, 2022, the Company consummated its Initial Public Offering of 11,500,000 Units (including the issuance of 1,500,000 Units as a result of the underwriter's full exercise of its over-allotment option), at $10.00 per Unit, generating gross proceeds of $115,000,000.

Each Unit consists of one share of Class A common stock and one redeemable warrant ("Public Warrant"). Each Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per share (see Note 6).

As of January 3, 2022, the Company incurred offering costs of approximately $6,762,886, of which $4,025,000 was for deferred underwriting commissions.

**Note 4 — Private Placement**

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 528,500 Placement Units at a price of $10.00 per Placement Unit ($5,285,000 in the aggregate).

The proceeds from the sale of the Placement Units were added to the net proceeds from the IPO held in the Trust Account. The Placement Units are identical to the Units sold in the Initial Public Offering, except for the placement warrants ("Placement Warrants"). If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Placement Warrants will expire worthless.

**Note 5 — Related Party Transactions**

**Founder Shares**

On May 11, 2021, the Sponsor purchased 2,875,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.009 per share. In June 2021, the Sponsor transferred 20,000 shares each to the Company's Chief Executive Officer and David Kopp, 15,000 shares to the Company's Chief Financial Officer and 10,000 shares to each of the Company's independent director nominees. In July 2021, the Sponsor also transferred 431,250 shares to ARC Group Limited. In November 2021, ARC Group Limited transferred 140,400 shares to Max Mark Capital Limited, 140,400 shares to Jonathan Chan, and 10,000 shares to Mei Eng Goy. ARC Group Limited purchased its net 140,450 shares in consideration of services provided by such party as financial advisor to the Company in connection with the Initial Public Offering. Each of the transfers above were completed at the same per share purchase price as the Sponsor paid for the founder shares, or $0.009. The number of founder shares issued was determined based on the expectation that such founder shares would represent 20% of the outstanding shares upon completion of the IPO (excluding the placement units and underlying securities). The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. As the underwriters' over-allotment option has been exercised in full, 375,000 of such shares held by the Sponsor will not be subject to forfeiture. As of September 30, 2024, the Sponsor owned 1 share of Class B common stock.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 5 — Related Party Transactions (Continued)**

The initial stockholders have agreed not to transfer, assign or sell any of the shares of Class B common stock (except to certain permitted transferees) until the earlier to occur of: (A) six months after the completion of the Company's initial business combination and (B) subsequent to the Company's initial business combination, (x) if the reported last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company's initial business combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company's stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

**Extension Loan**

The Company had 15 months from the closing of the Initial Public Offering (See Note 3) to consummate a Business Combination (the "Combination Period"). On March 23, 2023, the Company held a special meeting of its stockholders (the "Special Meeting"). At the Special Meeting, the Company's stockholders approved the proposal to amend the Company's amended and restated certificate of incorporation, to extend the date by which the Company must consummate a business combination up to twelve (12) times, each such extension for an additional one (1) month period from April 3, 2023 to April 3, 2024, by depositing into the trust account established for the benefit of the Company's public stockholders the lesser of (A) $0.055 per non-redeeming publicly held share of common stock and (B) $150,000 (the "Extension Payment") for each one-month extension. On March 5, 2024 the Company held an extraordinary meeting in lieu of the annual meeting whereby the Company's stockholders approved the proposal to amend the Company's amended and restated memorandum and articles of association to extend the date by which the Company has to consummate an initial business combination to thirty-six (36) months from the effectiveness date of the Company's Form S-1 by the SEC, which was December 29, 2021, by depositing into the Trust Account $0.033 per non-redeeming Public Share. As of September 30, 2024 and December 31, 2023 there was $1,800,000 and $885,000 outstanding under extension loans, respectively.

**Working Capital Loans**

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender's discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2024, there was $821,631 outstanding under Working Capital Loan. As of December 31, 2023, there was $537,431 outstanding under Working Capital Loan.

**Administrative Services Arrangement**

The Company's financial advisor has agreed, commencing from the date that the Company's securities are first listed on NASDAQ through the earlier of the Company's consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay the financial advisor $10,000 per month for these services. For the nine months ended September 30, 2024, the Company has recognized $30,000 operating cost for the service provided by ARC Group Ltd. under this agreement. This agreement is no longer in effect as of June 30, 2024. As of September 30, 2024 and December 31, 2023, the balance due under this agreement was $130,000 and $100,000, respectively. As a result of the termination of the agreement mentioned above, the administrative services previously provided by ARC Group Ltd. are currently being provided by the Sponsor at no monthly cost to the Company.

**Note 6 — Commitments and Contingencies**

**Registration Rights**

The holders of the insider shares, as well as the holders of the Placement Units (and underlying securities) and any securities issued in payment of Working Capital Loans made to the Company, will be entitled to registration rights pursuant to an agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities at any time after the Company consummates a Business Combination. In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

**AETHERIUM ACQUISITION CORP.**

**NOTES TO UNAUDITED FINANCIAL STATEMENTS**

**Note 6 — Commitments and Contingencies (Continued)**

**Underwriting Agreement**

The underwriters purchased the 1,500,000 of additional Units to cover over-allotments, less the underwriting discounts and commissions.

The underwriters were entitled to a cash underwriting discount of: (i) two percent (2.00%) of the gross proceeds of the Initial Public Offering, or $2,300,000 as the underwriters' over-allotment is exercised in full. In addition, the underwriters are entitled to a deferred fee of three and one half percent (3.50%) of the gross proceeds of the Initial Public Offering, or $4,025,000 upon closing of the Business Combination. The deferred fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.

On December 29, 2021 the underwriter gave the Company a rebatement of $500,000. So the cash underwriting fee for the Initial Public Offering was $1,800,000.

**Note 7 – Stockholders' Equity**

***Class A Common Stock*** — The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company's Class A common stock are entitled to one vote for each share. As of September 30, 2024, there were 3,403,499 shares of Class A Common Stock issued and outstanding, excluding 1,702,285 shares subject to redemption. As of December 31, 2023, there were 528,500 shares of Class A Common Stock issued and outstanding, excluding 2,991,003 shares subject to redemption.

On May 15, 2024, the holders of the Company's outstanding Founder Shares converted 2,874,999 Class B common stock into Class A common stock. Notwithstanding the conversions, such holders will not be entitled to receive any monies held in the Trust Account as a result of their ownership of any Class A common stock issued upon conversion of the Founder Shares. As of September 30, 2024, there were 2,874,999 non-redeemable Class A common stock included in the total 3,403,499 shares of Class A Common Stock issued and outstanding.

***Class B Common Stock*** — The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of the Company's Class B common stock are entitled to one vote for each share. On May 11, 2021, the Sponsor purchased 2,875,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.009 per share. On January 3, 2022, as the underwriters' over-allotment option has been exercised in full, 375,000 of such shares held by the Sponsor will not be subject to forfeiture. As of September 30, 2024 and December 31, 2023, there were 1 and 2,875,000 shares of Class B common stock issued and outstanding, respectively. Shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Company's initial business combination on a one-for-one basis. Refer above to the disclosure surrounding the May 15, 2024 conversion of Class B common stock to Class A common stock.

***Preferred Shares*** — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designation, rights and preferences as may be determined from time to time by the Company's Board of Directors. As of September 30, 2024 and December 31, 2023, there were no preferred shares issued or outstanding.

**Note 8 — Fair Value Measurements**

The following table presents information about the Company's financial assets that are measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Schedule of Fair Value Assets

---

| | | | |
|:---|:---|:---|:---|
|  | **Level** | **September 30, 2024** | **December 31, 2023** |
| Assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and marketable securities held in trust account | 1 | $- | $32931063 |

---

**Note 9 – Segment Information**

ASC Topic 280, "Segment Reporting," establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customer. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company's chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

The Company's chief operating decision maker has been identified as the Chief Executive Officer ("CODM"), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

When evaluating the Company's performance and making key decision regarding resource allocation, the CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statement of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets:

Schedule of Measure of Segment Assets Reported on Balance Sheet

---

| | |
|:---|:---|
|  | **September 30, 2024** |
| **Total Assets** | $19558443 |

---

---

| | |
|:---|:---|
|  | **For the**<br>**Nine Months Ended**<br>**September 30,**<br>**2024** |
| &nbsp;&nbsp;&nbsp;**TOTAL EXPENSES** | $1057192 |
| **OTHER INCOME** |  |
| &nbsp;&nbsp;&nbsp;Income earned on Cash and Investments held in Trust Account | $1007382 |
| &nbsp;&nbsp;&nbsp;**TOTAL OTHER INCOME** | $1007382 |

---

Expenses are reviewed and monitored by the CODM to management and forecast cash to ensure enough capital is available to complete an Initial Public Offering and eventually a Business Combination within the business combination period. The CODM also reviews costs to manage, maintain, and enforce all contractual agreements to ensure costs are aligned with all agreement and budget.

All other segment items included in net income or loss are reported on the statement of operations and described within their respective disclosures.

Total assets are reviewed and monitored by the CODM to determine if the Company has maintained enough capital in order to complete its initial Business Combination.

Income earned on cash and investments held in the Trust Account is reviewed and monitored by the CODM to determine returns for potential redeeming shareholders based on the interest earned on the holdings within the Trust Account.

**Note 10 – Subsequent Events**

In accordance with ASC Topic 855, "Subsequent Events", which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred through the date the unaudited financial statements were available to issue. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

As previously reported on a Current Report on Form 8-K, filed with the Securities and Exchange Commission on March 7, 2024, the Company entered into a business combination agreement on February 28, 2024 with Capital A Berhad, a Malaysian company ("Parent"), Capital A International, a Cayman Islands exempted company and a wholly-owned subsidiary of Parent ("PubCo"), Aether Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of PubCo ("Merger Sub") and Brand AA Sdn Bhd, a Malaysian company and a wholly-owned subsidiary of Parent. Unless otherwise defined herein, capitalized terms used herein shall have the meanings ascribed thereto in the Business Combination Agreement.

On October 23, 2024, the Company received written notice from Capital A Berhad that Parent had unilaterally terminated the Business Combination Agreement pursuant to Section 9.1(h) thereof because the Company received a Delisting Determination (as defined in the Business Combination Agreement). The Company previously received a written determination by Nasdaq to delist the Company's securities for failure to meet a continued listing standard. The Company's management and board were not made aware of Capital A Berhad's intent and decision to terminate the Business Combination agreement. Prior to its announcement, Capital A's management understood that the underlying basis for the Company remaining non-compliant on a single listing rule resulted from Capital A's delays in timely completing Form F-4 to the SEC. In addition, Capital A fully supported the Company through its Nasdaq extension requests and completed its Form F-4 several months ago. Since then, the Company has been waiting for Capital A to submit Form F-4 to the SEC to complete the business combination. The Company's board considers this unilateral termination of the BCA while simultaneously submitting a Regularization Plan ("RegPlan") to Bursa Malaysia that now excludes this business combination merger as not acting in good faith as the original RegPlan included this proposed merger. The Company regularly received reassurances that Capital A would seek to move forward in completing this business combination. The Company intends to engage with Capital A's management to understand further if Bursa Malaysia was preventing this transaction as an application for a listing on Nasdaq is a separate process, and no approvals are required until the SEC process is complete.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

References to the "Company," "us," "our" or "we" refer to Aetherium Acquisition Corp. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes included herein.

**Special Note Regarding Forward-Looking Statements**

All statements other than statements of historical fact included in this Form 10-Q including, without limitation, statements under "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding the Company's financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this Form 10-Q, words such as "anticipate," "believe," "estimate," "expect," "intend" and similar expressions, as they relate to us or the Company's management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

**Overview**

We are a blank check company formed under the laws of the State of Delaware on April 15, 2021 for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities ("Business Combination"). We intend to effectuate our Business Combination using cash from the proceeds of the IPO and the sale of the Private Warrants, our capital stock, debt or a combination of cash, stock and debt.

All activity through September 30, 2024 relates to our formation, IPO (as defined below), and search for a prospective initial business combination target.

We are incurring significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

**Results of Operations**

We have neither engaged in any operations nor generated any revenues to date. Our only activities from April 15, 2021 (inception) through September 30, 2024 were organizational activities, those necessary to consummate the IPO, as described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We generate non-operating income in the form of interest income on marketable securities held after the IPO. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the nine months ended September 30, 2024, we had a net loss of $229,860, which consisted of operating costs of $907,192, franchise tax expense of $150,000, and the provision for income taxes of $180,050, offset by interest earned on securities held in the Trust Account of $1,007,382.

For the three months ended September 30, 2024, we had a net loss of $252,395, which consisted of operating costs of $377,545, franchise tax expense of $50,000, and the provision for income taxes of $33,268, offset by interest earned on securities held in the Trust Account of $208,418.

For the nine months ended September 30, 2023, we had net income of $1,322,389, which consisted of interest earned on securities held in the Trust Account of $2,328,876 offset by operating costs of $398,923, franchise tax expense of $150,000 and the provision for income taxes of $457,564.

For the three months ended September 30, 2023, we had net income of $159,379, which consisted of interest earned on securities held in the Trust Account of $405,954 offset by operating costs of $121,825, franchise tax expense of $50,000 and the provision for income taxes of $74,750.

**Liquidity and Capital Resources**

On January 3, 2022, the Company consummated its Initial Public Offering of 11,500,000 units (the "Units" and, with respect to the shares of Class A common stock included in the Units being offered, the "Public Shares"), at $10.00 per Unit, generating gross proceeds of $115,000,000 (the "Initial Public Offering," or "IPO"), and incurring offering costs of $6,762,886, of which $4,025,000 was for deferred underwriting commissions. The Company granted the underwriter a 45-day option to purchase up to an additional 1,500,000 Units at the Initial Public Offering price to cover over-allotments, if any. On January 3, 2022, the over-allotment option was exercised in full. Simultaneously with the consummation of the closing of the IPO, the Company consummated the private placement of an aggregate of 528,500 units (the "Placement Units") to the Sponsor at a price of $10.00 per Placement Unit, generating total gross proceeds of $5,285,000 (the "Private Placement"). A total of $116,725,000 of the net proceeds from the IPO and the Private Placement was deposited in a trust account established for the benefit of the Company's public stockholders. The proceeds held in the trust account were invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. A total of $1,451,900 was deposited into the operating account of the Company.

As indicated in the accompanying financial statements, as of September 30, 2024, the Company had $207 of cash in its operating bank account and a working capital deficit of $6,109,436. Further, we have incurred and expect to continue to incur significant costs in pursuit of our financing and acquisition plans. We cannot assure you that our plans to raise capital or to consummate an initial business combination will be successful.

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds on a non-interest bearing basis as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial Business Combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into units, at a price of $10.00 per unit at the option of the lender, upon consummation of our initial Business Combination. The units would be identical to the Placement Units. Other than as described above, the terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

Moreover, we may need to obtain additional financing either to complete our initial Business Combination or because we become obligated to redeem a significant number of our public shares upon completion of our initial Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. In addition, we intend to target businesses larger than we could acquire with the net proceeds of the IPO and the sale of the Placement Units and may as a result be required to seek additional financing to complete such proposed initial Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial Business Combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

**Going Concern Consideration**

The Company expects to incur significant costs in pursuit of its financing and acquisition plans. In connection with the Company's assessment of going concern considerations in accordance with Accounting Standards Update ("ASU") 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the IPO, the requirement that the Company cease all operations, redeem the public shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern. The balance sheet does not include any adjustments that might result from the outcome of this uncertainty. The accompanying financial statement has been prepared in conformity with generally accepted accounting principles in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern.

**Related Party Transactions**

On May 11, 2021, the Sponsor purchased 2,875,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.009 per share. In June 2021, the Sponsor transferred 20,000 shares each to the Company's Chief Executive Officer and David Kopp, 15,000 shares to the Company's Chief Financial Officer and 10,000 shares to each of the Company's independent director nominees. In July 2021, the Sponsor also transferred 431,250 shares to ARC Group Limited. In November 2021, ARC Group Limited transferred 140,400 shares to Max Mark Capital Limited, 140,400 shares to Jonathan Chan, and 10,000 shares to Mei Eng Goy. ARC Group Limited purchased its net 140,450 shares in consideration of services provided by such party as financial advisor to the Company in connection with the Initial Public Offering. Each of the transfers above were completed at the same per share purchase price as the Sponsor paid for the founder shares, or $0.009. The number of founder shares issued was determined based on the expectation that such founder shares would represent 20% of the outstanding shares upon completion of the IPO (excluding the Placement Units and underlying securities). The per share purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the aggregate number of founder shares issued. As the underwriters' over-allotment option has been exercised in full, 375,000 of such shares held by the Sponsor will not be subject to forfeiture. As of September 30, 2024, the Sponsor owned 1 share of Class B common stock.

The Company's financial advisor has agreed, commencing from the date that the Company's securities are first listed on NASDAQ through the earlier of the Company's consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay the financial advisor $10,000 per month for these services.

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or the Company's officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans"). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender's discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2024, there was $821,631 outstanding under Working Capital Loans.

The Company had 15 months from the closing of the Initial Public Offering (See Note 3) to consummate a Business Combination (the "Combination Period"). On March 23, 2023, the Company held a special meeting of its stockholders (the "Special Meeting"). At the Special Meeting, the Company's stockholders approved the proposal to amend the Company's amended and restated certificate of incorporation, to extend the date by which the Company must consummate a business combination up to twelve (12) times, each such extension for an additional one (1) month period from April 3, 2023 to April 3, 2024, by depositing into the trust account established for the benefit of the Company's public stockholders the lesser of (A) $0.055 per non-redeeming publicly held share of common stock and (B) $150,000 (the "Extension Payment") for each one-month extension. On March 5, 2024 the Company held an extraordinary meeting in lieu of the annual meeting whereby the Company's stockholders approved the proposal to amend the Company's amended and restated memorandum and articles of association to extend the date by which the Company has to consummate an initial business combination to thirty-six (36) months from the effectiveness date of the Company's Form S-1 by the SEC, which was December 29, 2021, by depositing into the Trust Account $0.033 per non-redeeming Public Share. As of September 30, 2024 and December 31, 2023 there was $1,800,000 and $885,000 outstanding under extension loans, respectively.

On January 3, 2022, concurrent with the closing of the IPO, the Sponsor purchased an aggregate of 528,500 Placement Units at a price of $10.00 per unit for an aggregate purchase price of $5,285,000. Each Placement Unit consists of one share of Class A common stock and one warrant. Each warrant is exercisable to purchase one share of Class A common stock at $11.50 per share. There are no redemption rights or liquidating distributions from the trust account with respect to the founder shares, the placement shares, or the placement warrants, which will expire worthless if we do not consummate a Business Combination within 15 months from the closing of the IPO, or April 3, 2023. The Placement Units are identical to the units sold in the IPO except that the Placement Units and their component securities (a) will not be transferable, assignable or saleable until 30 days after the consummation of our initial Business Combination except to permitted transferees and (b) so long as they are held by our Sponsor or its permitted transferees, will be entitled to registration rights.

Our initial stockholders have agreed to waive their redemption rights with respect to their founder shares and placement shares (i) in connection with the consummation of a Business Combination, (ii) in connection with a stockholder vote to amend our Amended and Restated Certificate of Incorporation (A) to modify the substance or timing of our obligation to allow redemption in connection with our initial Business Combination or certain amendments to our Amended and Restated Certificate of Incorporation prior thereto or to redeem 100% of our public shares if we do not complete our initial Business Combination within 15 months from the completion of the IPO or (B) with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activities and (iii) if we fail to consummate a Business Combination within 15 months from the completion of the IPO or if we liquidate prior to the expiration of the 15-month period. However, our initial stockholders will be entitled to redemption rights with respect to any public shares held by them if we fail to consummate a Business Combination or liquidate within the 15-month period.

Pursuant to a registration rights agreement we have entered into with our initial stockholders, we may be required to register certain securities for sale under the Securities Act. These holders, and holders of units issued upon conversion of working capital loans, if any, are entitled under the registration rights agreement to make up to three demands that we register certain of our securities held by them for sale under the Securities Act and to have the securities covered thereby registered for resale pursuant to Rule 415 under the Securities Act. In addition, these holders have the right to include their securities in other registration statements filed by us. We will bear the costs and expenses of filing any such registration statements. See the section of this prospectus entitled "Certain Relationships and Related Party Transactions."

**Off-balance sheet financing arrangements**

We did not have any off-balance sheet arrangements as of September 30, 2024.

**Critical Accounting Policies**

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. As of September 30, 2024, there were no critical accounting policies.

**Recent accounting standards**

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our financial statements.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

We are a smaller reporting company and are not required to provide the information otherwise required under this item.

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective.

**Changes in Internal Control over Financial Reporting**

During the quarter ended September 30, 2024, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II - OTHER INFORMATION**

**Item 1 Legal Proceedings**

The Company is not party to any legal proceedings as of the filing date of this Form 10-Q.

**Item 1A. Risk Factors.**

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our final prospectus for our IPO dated December 29, 2021 and filed with the SEC on January 3, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

*Recent Sale of Unregistered Securities*

None.

*Use of Proceeds*

For a description of the use of the proceeds generated in the IPO, see Part I, Item 2 of this Quarterly Report on Form 10-Q.

*Purchases of Equity Securities by the Issuer and Related Purchasers*

None.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not Applicable.

**Item 5. Other Information.**

None.

**Item 6. Exhibits**

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

---

| | |
|:---|:---|
| **Exhibit**<br> **No.** | **Description** |
| 3.1 | [Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 filed with the Form 8-K filed by the Registrant on January 4, 2022)](https://www.sec.gov/Archives/edgar/data/1866547/000149315222000323/ex3-1.htm). |
| 3.2 | [Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 filed with the Form 8-K filed by the Registrant on January 4, 2022)](https://www.sec.gov/Archives/edgar/data/1866547/000149315222000323/ex3-2.htm). |
| 31.1 | [Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm). |
| 31.2 | [Certification of Principal Financial and Accounting Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm). |
| 32.1\* | [Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm). |
| 32.2\* | [Certification of Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm). |
| 101.INS | Inline XBRL Instance Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

**SIGNATURES**

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **AETHERIUM ACQUISITION CORP.** | **AETHERIUM ACQUISITION CORP.** |
| Date: July 31, 2025 | By: | */s/ Jonathan Chan* |
|  |  | Jonathan Chan |
|  |  | Chief Executive Officer |

---

---

| | | |
|:---|:---|:---|
| Date: July 31, 2025 | By: | */s/ Alex Lee* |
|  |  | Alex Lee |
|  |  | Chief Financial Officer |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION**

**PURSUANT TO RULES 13a-14(a) AND 15d-14(a)**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Jonathan Chan, certify that:

1. I
 have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 of Aetherium Acquisition Corp.;

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
 the period covered by this report;

3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
 respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
 this report;

4. The
 registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a. Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this report is being prepared;

b. [Paragraph
 omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

c. Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
 and

d. Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
 registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
 financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or
 persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a. All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

b. Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal controls over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: July 31, 2025 | By: | */s/ Jonathan Chan* |
|  |  | Jonathan Chan |
|  |  | Chief Executive Officer |
|  |  | (Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION** 

**PURSUANT TO RULES 13a-14(a) AND 15d-14(a)**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Alex Lee, certify that:

1. I
 have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 of Aetherium Acquisition Corp.;

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
 to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
 the period covered by this report;

3. Based
 on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
 respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
 this report;

4. The
 registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;a. Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this report is being prepared;

b. [Paragraph
 omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

c. Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
 and

d. Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The
 registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
 financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or
 persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;a. All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

b. Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal controls over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: July 31, 2025 | By: | */s/ Alex Lee* |
|  |  | Alex Lee |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Aetherium Acquisition Corp. (the "<u>Company</u>") on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the "<u>Report</u>"), I, Jonathan Chan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: July 31, 2025 |  | */s/ Jonathan Chan* |
|  | Name: | Jonathan Chan |
|  | Title: | Chief Executive Officer |
|  |  | (Principal Executive Officer) |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION PURSUANT TO 31**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Aetherium Acquisition Corp. (the "<u>Company</u>") on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the "<u>Report</u>"), I, Alex Lee, Chief Financial and Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: July 31, 2025 |  | */s/ Alex Lee* |
|  | Name: | Alex Lee |
|  | Title: | Chief Financial Officer |
|  |  | (Principal Financial and Accounting Officer) |

---